Financial Year |
March 31 2023 |
Monetary Funds |
1,368,369,035.61 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
102,447,653.88 |
Accounts Receivable |
1,093,799,844.95 |
Advances to Suppliers |
84,611,101.21 |
Other Receivables |
115,833,047.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
300,000.00 |
Inventories |
1,482,352,682.78 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
227,124,162.61 |
Total Current Assets |
4,620,529,345.60 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
1,173,445,266.72 |
Long-term Equity Investment |
972,569,935.90 |
Investment Properties |
692,874,349.18 |
Fixed Assetes |
576,822,430.04 |
Under-construction Projects |
126,399,666.61 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
56,384,491.09 |
R&D expenses |
-- |
Goodwill |
293,779,418.70 |
Long-Term Deferred and Prepaid Expenses |
14,796,098.18 |
Deferred Income Tax Assets |
270,351,137.24 |
Other Non-Current Assets |
1,476,334,213.94 |
Sub-Total of Non-Current Assets |
5,727,208,360.38 |
Total Assets |
10,347,737,705.98 |
Short-Term Loans |
1,105,769,183.35 |
Trading Financial liabilities |
-- |
Notes Payable |
64,678,018.04 |
Accounts Payable |
1,177,500,901.05 |
Accounts Received In Advance |
23,923,270.24 |
Employee Compensation Payable |
280,601,861.46 |
Taxes Payable |
16,420,512.97 |
Interest Payable |
6,801,190.97 |
Dividend Payable |
-- |
Other payables |
154,095,241.82 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
411,213,455.48 |
Other Current Liabilities |
65,665,590.55 |
Sub-Total of Current Liabilities |
4,101,454,636.15 |
Long-term Loans |
2,398,125,816.15 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
194,866,666.64 |
Special Payable |
-- |
Estimatied Liabilities |
13,363,907.27 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
49,339,300.00 |
Sub-Total of Non-Current Liabilities |
2,806,356,175.45 |
Total Liabilities |
6,907,810,811.60 |
Paid-In Capital(Or Share Stock) |
452,517,400.00 |
Capital Surplus |
887,172,773.22 |
Surplus Reserve |
253,981,469.50 |
LESS:Treasury Stock |
52,571,925.80 |
Undistributed Profits |
1,603,030,649.42 |
Minority Stockholder's Interest |
297,830,297.93 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,142,096,596.45 |
Owner's Equity(Stockholder's Equity) |
3,439,926,894.38 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
10,347,737,705.98 |